Next Article in Journal
Fentanyl and Spiradoline Interactions in a Place-Conditioning Black-White Shuttle-Box
Previous Article in Journal
Anticoagulation in the Elderly
Open AccessCommentary

Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’

BIAL - Portela & Ca, S.A., S. Mamede do Coronado, Portugal
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(12), 3629-3632; https://doi.org/10.3390/ph3123629
Received: 9 November 2010 / Accepted: 16 December 2010 / Published: 17 December 2010
(This article belongs to the Special Issue Antiepileptic Drugs)
The recent review of Matthew D. Krasowski on ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’ is a useful foundation of comparative interpretations on our current knowledge about therapeutic drug monitoring. Within the review, the statement that therapeutic drug monitoring has a minimal role in the therapeutic use of eslicarbazepine acetate due to its relatively predictable pharmacokinetics reflects the existing body of evidence although some information such as eslicarbazepine acetate’s chemical structure, proportions of its metabolites, their pharmacokinetics and chiral method of plasma level measurement need to be revised. These critical characteristics differentiate the novel compound from former dibenzazepines such as carbamazepine and oxcarbazepine in its clinical effects and needs for therapeutic drug monitoring. View Full-Text
Keywords: anticonvulsants; anti-epileptic drugs; drug monitoring; drug toxicity; epilepsy; seizures; carbamazepine; oxcarbazepine; eslicarbazepine acetate anticonvulsants; anti-epileptic drugs; drug monitoring; drug toxicity; epilepsy; seizures; carbamazepine; oxcarbazepine; eslicarbazepine acetate
Show Figures

Graphical abstract

MDPI and ACS Style

Öztiryaki, A.H.; Soares-da-Silva, P. Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’. Pharmaceuticals 2010, 3, 3629-3632.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop